Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) CEO Amit Gupta sold 6,498 shares of the stock in a transaction on Thursday, July 2nd. The shares were sold at an average price of $4.39, for a total value of $28,526.22. Following the completion of the transaction, the chief executive officer directly owned 123,490 shares in the company, valued at $542,121.10. This trade represents a 5.00% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Amit Gupta also recently made the following trade(s):
- On Monday, July 6th, Amit Gupta sold 9,640 shares of Cardlytics stock. The shares were sold at an average price of $4.39, for a total value of $42,319.60.
Cardlytics Price Performance
Shares of NASDAQ CDLX opened at $4.01 on Thursday. The business has a 50-day moving average of $6.06 and a two-hundred day moving average of $8.62. The company has a market capitalization of $23.30 million, a price-to-earnings ratio of -0.23 and a beta of 0.61. Cardlytics, Inc. has a 1 year low of $3.95 and a 1 year high of $32.80.
Wall Street Analysts Forecast Growth
Read Our Latest Research Report on CDLX
Institutional Trading of Cardlytics
Institutional investors and hedge funds have recently made changes to their positions in the company. Bank of America Corp DE boosted its position in shares of Cardlytics by 262.7% in the 3rd quarter. Bank of America Corp DE now owns 1,632,786 shares of the company’s stock valued at $3,968,000 after purchasing an additional 1,182,593 shares during the period. Quinn Opportunity Partners LLC increased its position in Cardlytics by 900.0% during the third quarter. Quinn Opportunity Partners LLC now owns 1,100,000 shares of the company’s stock worth $2,673,000 after buying an additional 990,000 shares during the period. UBS Group AG increased its position in Cardlytics by 112.5% during the third quarter. UBS Group AG now owns 458,066 shares of the company’s stock worth $1,113,000 after buying an additional 242,536 shares during the period. Raymond James Financial Inc. lifted its stake in Cardlytics by 36,915.3% in the third quarter. Raymond James Financial Inc. now owns 133,255 shares of the company’s stock valued at $324,000 after buying an additional 132,895 shares during the last quarter. Finally, Jane Street Group LLC boosted its holdings in shares of Cardlytics by 263.0% in the second quarter. Jane Street Group LLC now owns 162,427 shares of the company’s stock valued at $267,000 after acquiring an additional 117,687 shares during the period. 68.10% of the stock is owned by hedge funds and other institutional investors.
Cardlytics Company Profile
Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.
At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.
Featured Articles
- Five stocks we like better than Cardlytics
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.
